pharmaphorum

Media Perspectives: William Looney

RachelASharpe — Fri, 25 May 2012 14:38:18 +0000

In our latest Media Perspectives interview, we speak to William Looney from Pharmaceutical Executives about his highlights as Editor-In-Chief and his thoughts on some of this year’s top pharma news stories. Our Media Perspectives series gives us an insight into the lives of those working within both the media and pharma industries...

Has the push for transparency gone too far? (Part 2)

RachelASharpe — Fri, 25 May 2012 09:48:54 +0000

Darshan Kulkarni continues his look into the Sunshine Act questioning whether our quest for transparency has gone too far. Without the appropriate connotations as to why these payments were made, the Sunshine Act seems to cast physicians in a bad light...

AstraZeneca joins NewDrugs4BadBugs research programme

Paul — Thu, 24 May 2012 08:45:25 +0000

Dr John Rex of AstraZeneca discusses the Innovative Medicines Initiative’s NewDrugs4BadBugs programme, which will bring big pharma companies together to share research in the fight against infection. The increasing bacterial resistance to antibiotics is a growing problem and global health issue. Seventy years ago the discovery of antibiotics for the...

Biotrinity 2012

RachelASharpe — Wed, 23 May 2012 09:21:46 +0000

Rebecca Aris provides an overview of some of the topics discussed at the ‘Biotrinity 2012’ conference. Last month OBN hosted Biotrinity 2012 at Newbury racecourse in the UK. The conference saw a large VC turn-out and presented a great...

Networked integration required for healthcare gamification to succeed

RachelASharpe — Tue, 22 May 2012 08:40:23 +0000

Richard Law continues his look into gamification and highlights the importance of network integration. Previously we looked at the opportunities for healthcare gamification, and looked at examples such as...

Does pharma need a little creative destruction?

RachelASharpe — Mon, 21 May 2012 09:13:43 +0000

Dr Eric Topol of The Scripps Research Institute and Scripps Health speaks to us about the technological healthcare space, the challenges facing pharma and what he believes the future looks like. The healthcare landscape has changed rapidly over the past century and today’s influx of technology is proving to be...

Mobile – the device powering the next big evolution of human health behavior

RachelASharpe — Fri, 18 May 2012 15:10:57 +0000

Continuing our mHealth theme this month, Leigh Householder investigates how mobile is changing human behaviour, particularly with regards to health. Maybe you've had this debate: Is mobile a device, a channel, or a behavior? A tool, a place, a fundamental change? Arguably, it's all...

The ageing population – the need for pharma to be disruptive in addressing the needs of senior consumers

RachelASharpe — Fri, 18 May 2012 09:15:20 +0000

Following our mobile health theme, Dr. Michael Reilly shares his views on how pharma needs to address the ageing population. This article calls for new, disruptive and radical approaches by Pharma to address the issue of managing and delivering healthcare into...

Tunnah’s musings: is being app-ey the key to good health?

HannahBlake — Thu, 17 May 2012 13:39:00 +0000

Mobile health themed musings from Paul Tunnah this month, as he ponders whether the world of pharma drugs and mhealth apps might not be so different. It may have escaped your notice so far but we’ve started having themed months on the pharmaphorum site, where we focus a slightly higher volume …

Has the push for transparency gone too far? (Part 1)

RachelASharpe — Thu, 17 May 2012 09:35:47 +0000

Darshan Kulkarni asks if the push for transparency, as initiated by the Sunshine Act in the US, has gone too far. There has been a recent surge in requests for disclosures of relationships between individuals and pharmaceutical, biopharmaceutical…